Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial (Q46322891)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial |
scientific article |
Statements
1 reference
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial (English)
1 reference
Michael G Hennerici
1 reference
Henrik Sillesen
1 reference
Pierre Amarenco
1 reference
Alfred Callahan
1 reference
Larry B Goldstein
1 reference
Justin Zivin
1 reference
Michael Messig
1 reference
K Michael Welch
1 reference
Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators
1 reference
9 October 2008
1 reference
1 reference
39
1 reference
12
1 reference
3297-3302
1 reference